Serum lipids and cardiac function correlate with nitrotyrosine and MMP activity in coronary artery disease patients

AIMS: Peroxynitrite - matrix metalloproteinase (MMP) signaling has been shown to contribute to myocardial ischemia/reperfusion injury and heart failure and to be influenced by hyperlipidemia in preclinical models. Therefore, here we investigated the correlation between the markers of peroxynitrite...

Teljes leírás

Elmentve itt :
Bibliográfiai részletek
Szerzők: Bencsik Péter
Sasi Viktor
Kiss Krisztina
Kupai Krisztina
Kolossváry Márton József
Maurovich-Horvat Pál
Csont Tamás Bálint
Ungi Imre
Merkely Béla Péter
Ferdinandy Péter
Dokumentumtípus: Cikk
Megjelent: Springer-Verlag 2015
Sorozat:EUROPEAN JOURNAL OF CLINICAL INVESTIGATION 45 No. 7
doi:10.1111/eci.12458

mtmt:2890323
Online Access:http://publicatio.bibl.u-szeged.hu/11802
LEADER 03179nab a2200313 i 4500
001 publ11802
005 20200117154226.0
008 170726s2015 hu o 0|| zxx d
022 |a 0014-2972 
024 7 |a 10.1111/eci.12458  |2 doi 
024 7 |a 2890323  |2 mtmt 
040 |a SZTE Publicatio Repozitórium  |b hun 
041 |a zxx 
100 1 |a Bencsik Péter 
245 1 0 |a Serum lipids and cardiac function correlate with nitrotyrosine and MMP activity in coronary artery disease patients  |h [elektronikus dokumentum] /  |c  Bencsik Péter 
260 |a Springer-Verlag  |c 2015 
300 |a 692-701 
490 0 |a EUROPEAN JOURNAL OF CLINICAL INVESTIGATION  |v 45 No. 7 
520 3 |a AIMS: Peroxynitrite - matrix metalloproteinase (MMP) signaling has been shown to contribute to myocardial ischemia/reperfusion injury and heart failure and to be influenced by hyperlipidemia in preclinical models. Therefore, here we investigated the correlation between the markers of peroxynitrite - MMP signaling and hyperlipidemia in patients with significant coronary stenosis. METHODS: Five minutes before percutaneous coronary intervention (PCI), arterial blood samples were collected from 36 consecutive coronary artery disease (CAD) patients selected for elective PCI. RESULTS: Serum nitrotyrosine positively correlated with MMP-9 activity (r=0.54, p=0.01) but not with MMP-2 activity. Nitrotyrosine positively correlated with total (r=0.58; p<0.01) and LDL cholesterol (r=0.55; p<0.01), serum triglyceride (r=0.47; p<0.05), and creatinine (r=0.42; p<0.05), and negatively correlated with HDL cholesterol (r=-0.46; p<0.05) and with left ventricular ejection fraction (LVEF; r=-0.55; p<0.05), respectively. MMP-2 activity correlated positively with total (r=0.55; p<0.05) and LDL cholesterol (r=0.45; p<0.05). In statin-treated patients, a significantly reduced serum nitrotyrosine was found as compared to statin naives, however, MMP activities and serum cholesterol levels were not different. MMP-9 activity correlated with urea nitrogen (r=0.42; p<0.05) and LVEF (r=-0.73; p<0.01). Serum creatinine correlated negatively with LVEF (r=-0.49, p<0.05). CONCLUSIONS: This is the first demonstration that (i) serum nitrotyrosine correlates with MMP-9 activity, (ii) lipid parameters correlate with nitrotyrosine and MMP-2 activity, (iii) myocardial function correlates with creatinine, nitrotyrosine, and MMP-9 activity, and (iv) creatinine correlates with nitrotyrosine and urea nitrogen with MMP-9 activity in CAD patients. Studying the biomarkers of peroxynitrite - MMP pathway in large prospective trials may reveal their diagnostic avails. This article is protected by copyright. All rights reserved. 
700 0 1 |a Sasi Viktor  |e aut 
700 0 1 |a Kiss Krisztina  |e aut 
700 0 1 |a Kupai Krisztina  |e aut 
700 0 1 |a Kolossváry Márton József  |e aut 
700 0 2 |a Maurovich-Horvat Pál  |e aut 
700 0 2 |a Csont Tamás Bálint  |e aut 
700 0 2 |a Ungi Imre  |e aut 
700 0 2 |a Merkely Béla Péter  |e aut 
700 0 2 |a Ferdinandy Péter  |e aut 
856 4 0 |u http://publicatio.bibl.u-szeged.hu/11802/1/Bencsik_et_al_2015_European_Journal_of_Clinical_Investigation_published_u.pdf  |z Dokumentum-elérés